by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
Conditions: Torticollis Congenital; Motor Development; Sensory Integration Dysfunction Sponsors: Gazi University Recruiting Conditions: Torticollis Congenital; Motor Development; Sensory Integration Dysfunction Sponsors: Gazi University...
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood cancers has shown a 73 per cent response rate among patients in India. Read on to know more. A new study published in The Lancet Haematology...
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
A drug targeting the scaffolding function of multiple related kinases halts tumor progression. A drug targeting the scaffolding function of multiple related kinases halts tumor progression.
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
Oligonucleotides are one of the fastest growing segments in the pharmaceutical industry. These molecules are extensively utilized in biopharmaceutical and… Oligonucleotides are one of the fastest growing segments in the pharmaceutical industry. These...
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
University of Twente’s Mark Schuuring, MD, Ph.D. explores how digital health tools can successfully support heart failure interventions, despite hesitancy from providers and skepticism about the interest and abilities of a more senior patient population....
by palligoelme@gmail.com | Mar 17, 2025 | Clinical Trials
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in India, according to results of clinic… An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent...
